Johnson & Johnson Corrective Wave May End Soon!After the motive wave on JNJ, the stock is now going through some corrections. Now that the stock price is close to the lower part of the bullish wedge, any rejection with a strong bullish candlestick could cause the price to re-test its upper part...
N.B
- Let emotions and sentiments work for you
-ALWAYS Use Proper Risk Management In Your Trades
JNJ
Johnson & Johnson Technical AnalysisWait Before buying - check if the support level will not be broken before buying, otherwise hold
Fundamental Analysis
Johnson & Johnson (NYSE:JNJ) began researching vaccine candidates in January, as soon as the COVID-19 sequence became available.
A Phase 1 clinical trial of the novel coronavirus vaccine is planned for September, with data regarding safety and efficacy available by the end of the year. If all goes accordingly, the vaccine could be ready “for emergency use” in early 2021.
As part of this commitment, Johnson & Johnson will scale up its manufacturing capacity in the U.S. and other countries in order to enable the supply of more than 1 billion doses of the vaccine when it is ready.
Johnson & Johnson Trade Idea #JNJThere's an old saying that goes by "Sell in May, and go away until Labor Day"
As #JNJ continues to make lower lows, by bias is shifting towards the bearish outlook.
I know sometimes it's tough deciding when to close positions and lock-in profit because you fear you might miss out on the right opportunity to re-enter the trade. If that's the concern, what I suggest is to continue to manually trail a pending "Buy Limit" order above the highs of each candle. As the price continues to fall, continue to manually adjust the trailing pending buy limit. This way once price action makes that higher high, our trading platform will automatically execute our buy position from the pending buy limit order.
If anyone has any questions, feel free to leave them in the comment section below.
Trade Safe - Trade Well
Warm Regards,
Michael Harding
Will this be a great VBIV buy in?I've been actively trading the recent VBIV bull run, and I still expect the bull run to continue from now until year's end. However, the stock is up over 100% in a very short time, and this may be the correction to this rapid movement.
I'm not actively trading this idea yet, but I will update the idea if I decide to short.
Remember folks, just ideas!
JNJ - even essential companies are going to slow down!Along with Tech stocks, essential companies like JNJ are experiencing resistance. This isn't the cleanest pattern nor my typical level for the stop of this pattern, however given the surrounding environment of other stick in this sector - I like this risk/reward for the first target.
Gild Bullish trend-line PlayGilead Sciences , Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company's products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency virus (HIV) infection; and Vosevi, Vemlidy, Epclusa, Harvoni, and Viread products for treating liver diseases.
Entry $77.50 area
Target $2 trailing stoploss
I been trading this stock for over a year now and once it form it's base, it usually hold itself very well in it's pattern.
we could've easily scalped this stock multiple time this month for easy gain if you just buy the dip at the trend line with a tight stoploss.
JNJ: Bearish Breakdown Analysis 4H (Apr. 26)X FORCE GLOBAL ANALYSIS:
Johnson & Johnson has shown great momentum in its small rally over the past few weeks. However, technicals demonstrate signs of prices having temporarily topped out.
Technical Analysis
- The first thing we spot is a textbook bearish divergence.
- Prices form higher highs, while the Relative Strength Index (RSI) forms lower highs
- The Moving Average Convergence Divergence (MACD) has formed a death cross, with increasing bearish histograms
- We have broken down from the ascending parallel channel, and the support has now become resisance
- Prices have been testing the upper resistance of the Bollinger bands, and a test of the lower support is highly likely
- We have two price gaps on the 4H chart, waiting to get potentially filled
- The volume is decreasing as bearish tensions increase
What We Believe
Although JNJ is a fundamentally sound stock, and still great for the long run, short term technicals demonstrate a potential downside.
Trade Safe.
JOHNSON & JOHNSON (JNJ) Monthly, Weekly & DailyTrades made when the monthly, weekly and daily arrows are pointing in the same direction
are the most profitable.
For best results trade in the direction of the trend.
The Linear Regression channel is used to determine trend direction. The Linear Regression is set at 2 -2 30.
When a green Henikin Ashi candle intersects with the linear regression upper deviation line (green line) and both indicators intersect with a Djinn prediction date a sell is triggered.
When a red Henikin Ashi candle intersects with the linear regression lower deviation line (red line) and both indicators intersect with a Djinn prediction date a buy is triggered.
This trading strategy works on daily, weekly and Monthly Djinn Predictive charts.
This is not trading advice. Trade at your own risk.
$JNJ Breaks Out as Company Moves into Coronavirus LottoJNJ just entered the fray as the newest bona fide COVID-19 "play" given its claim to have a serious vaccine candidate.
The stock broke above range and MA resistance to kick off the week, and still has a bullish trend on a long time frame according to the Ichimoku Cloud indicator.
JOHNSON & JOHNSON (JNJ) TOP-DOWN ANALYSIS & TRADING PLAN!
hey guys,
JNJ is retesting the major recently broken trendline.
Chances are high that the market may drop from that and here is how we can catch this wave!
pay attention to a horizontal decision range on 1H.
bearish breakout of it will be a perfect trigger to short!
initial target - 111.0
then apply trailing stop to catch occasional panic selloff.
if the market goes above the falling trendline on 4H, our setups will be invalid and our bias shifts to bullish!
good luck!
JNJ Consolidates - 2 Reasons to BuyIf you are looking at JNJ stock right now, the price is consolidating between 150-154. However, the trend is extremely bullish. Nearly every technical indicator is positive. Read my short analysis at Johnson & Johnson Stock Consolidates. Should You Buy JNJ for the Dividend?
your mum uses these productsok anyone with half a brain can see this bad boy is in a strong uptrend. red hollow momo hammer bouncing at the bottom of the channel.
i circled a very strong pattern looks like it needed to close above 149 to confirm it (which it did) very strongly
they also are working on a corona virus vax. so lots of plays in store for this bad boy
if it breaks ath it can see a serious run here. short term target 153.20 long term 170